A Webinar on PARP Inhibitors in Epithelial Ovarian Cancer

What Clinical Trials Are Recruiting for Recurrent Ovarian Cancer?Подробнее

Oncology beyond the Obvious Webinar Series 17Подробнее

Novel Therapeutics in Ovarian Cancer: What to WatchПодробнее

Webinar on "Expanding Role of Parp Inhibitors In Treating Ovarian Cancer ".Подробнее

Webinar: Genetics and Ovarian Cancer (Full)Подробнее

Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel ApproachesПодробнее

Tackling Platinum Resistant Ovarian CancerПодробнее

Innovative and Emerging Trials in Ovarian CancerПодробнее

Emerging & Promising Clinical Trials in Ovarian Cancer: Learn the LatestПодробнее

PARP Inhibitors in 2020: Where Are We Now, and Where Are We Going | Webinar | Ambry GeneticsПодробнее

Webinar: PARP Inhibitors and Ovarian CancerПодробнее

Live Webinar on Advanced Ovarian Cancer Prolonging Survival in the Present DecadeПодробнее

Dr. Krishnansu Tewari: Ovarian Cancers- Epithelial Tumors of the PelvisПодробнее

3/26/2021: Upfront Treatment of Advanced Ovarian Cancer; Ay, Now the Plot ThickensПодробнее

PARP Inhibitors in Ovarian Cancer Treatment | Webinar | Ambry GeneticsПодробнее

Webinar: Latest Developments into Ovarian Cancer with Dr Yolanda AntillПодробнее

Updates in Ovarian Cancer: Frontline MaintenanceПодробнее

Webinar: Latest Developments into Ovarian Cancer FULLПодробнее

New PARP Inhibitor Drug Approved to Treat Women with Recurrent Ovarian CancerПодробнее